Upgrade to SI Premium - Free Trial

Intelligent Bio Solutions completes usability study for FDA submission

August 5, 2026 8:30 AM
Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the completion of a usability study for its Intelligent Fingerprinting Drug Screening System ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA